SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodiesResearch Article Published on 2022-04-052022-10-04 Journal: Science Translational Medicine [Category] [DOI] 10.1126/scitranslmed.abn8543 PMC 바로가기 [Article Type] Research Article
Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers의료 종사자에서 비활성화된 COVID-19 백신의 안전성 및 면역원성Article Published on 2022-04-012022-09-11 Journal: Journal of medical virology [Category] [DOI] 10.1002/jmv.27458 PMC 바로가기 [Article Type] Article
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansSARS-CoV-2 단일클론항체 조합인 AZD7442는 인간이 아닌 영장류를 보호하고 인간에서 반감기가 연장됩니다.Article Published on 2022-03-092022-09-11 Journal: Science Translational Medicine [Category] [DOI] 10.1126/scitranslmed.abl8124 PMC 바로가기 [Article Type] Article
Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort StudyResearch article Published on 2022-03-012022-10-05 Journal: The American journal of medicine [Category] [DOI] 10.1016/j.amjmed.2021.10.026 [Article Type] Research article
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis투석 중인 환자의 mRNA-1273(모더나)과 BNT162b2(화이자-바이오엔텍) SARS-CoV-2 백신 면역원성의 차이Observational Study Published on 2022-02-282022-09-11 Journal: CMAJ : Canadian Medical Association journal = jour [Category] [DOI] 10.1503/cmaj.211881 PMC 바로가기 [Article Type] Observational Study
Aggregation of high‐frequency RBD mutations of SARS‐CoV‐2 with three VOCs did not cause significant antigenic driftResearch Article Published on 2022-01-282022-10-04 Journal: Journal of medical virology [Category] [DOI] 10.1002/jmv.27596 PMC 바로가기 [Article Type] Research Article
Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil브라질에서 SARS-CoV-2 감마 변종에 의한 재감염 및 백신 돌파 후 급성 COVID-19 증후군Case Reports Published on 2022-01-012022-09-11 Journal: International Journal of Infectious Diseases [Category] [DOI] 10.1016/j.ijid.2021.10.048 PMC 바로가기 [Article Type] Case Reports
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial성인에서 홍역 벡터 기반 SARS-CoV-2 백신 후보 V591의 안전성 및 면역원성: 1/2상 무작위, 이중 맹검, 위약 대조, 용량 범위 시험 결과Clinical Trial Published on 2022-01-012022-09-11 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2021.103811 PMC 바로가기 [Article Type] Clinical Trial
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccinationSARS-CoV-2 Lambda 변이체의 단일 클론 항체 및 감염 및 백신 접종에 의해 유도된 중화 항체에 대한 감수성 감소Coronaviruses Published on 2021-12-212022-09-10 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2021.2008775 PMC 바로가기 [Article Type] Coronaviruses
Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral InfectionsArticle Published on 2021-12-112022-10-28 Journal: Viruses [Category] [DOI] 10.3390/v13122489 PMC 바로가기 [Article Type] Article